Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Biomarkers in Urology, An Issue of Urologic Clinics
- 1st Edition, Volume 50-1 - November 23, 2022
- Editor: Adam Feldman
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 4 0 1 9 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 4 0 2 0 - 7
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.
-
Contains 15 practice-oriented topics including biomarkers in pediatric urology; unleashing the urinary microbiome in benign urologic disease; biomarkers for detection and assessment of clinically significant prostate cancer; biomarkers in testicular cancer: classic tumor markers and beyond; and more.
-
Provides in-depth clinical reviews on biomarkers in urology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Urology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Foreword
- Preface
- Approaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology
- Key points
- Introduction
- Results
- Discussion
- Summary
- Clinics care points
- Disclosure
- Biomarkers in Urolithiasis
- Key points
- Introduction
- Markers of ureteral obstruction and kidney injury
- Sepsis
- Genetics
- Summary
- Clinics care points
- Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- Pathophysiology and Clinical Biomarkers in Interstitial Cystitis
- Key points
- Introduction
- Methods
- Results
- Discussion
- Summary
- Clinics care points
- Disclosures
- Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non–muscle-Invasive Bladder Cancer
- Consultant
- Key points
- Introduction
- Diagnosis
- Surveillance
- Prognosis
- Summary
- Clinics care points
- Disclosure
- Biological Stratification of Invasive and Advanced Urothelial Carcinoma
- Key points
- Introduction
- Methods
- Progression from non–muscle-invasive bladder cancer to muscle-invasive bladder cancer
- Biological stratification of muscle-invasive bladder cancer
- Biological stratification of metastatic urothelial carcinoma
- Summary
- The Association Between the Urinary Microbiome and Bladder Cancer
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer
- Key points
- Introduction
- Study selection
- Findings
- Discussion
- Summary
- Clinics care points
- Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
- Key points
- Key/essential headings
- Discussion
- Summary
- Clinics care points
- Targeted Molecular Imaging as a Biomarker in Urologic Oncology
- Key points
- Introduction
- Prostate cancer
- Renal cancer
- Bladder cancer
- Other urologic cancers
- Summary
- Clinics care points
- Disclosures
- Acknowledgments and funding source
- Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosures
- The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
- Key points
- Introduction
- Human papillomavirus-dependent pathways
- Human papillomavirus-independent pathways
- Summary
- Clinics care points
- Disclosures
- Current and Future Biomarkers in the Management of Renal Cell Carcinoma
- Key points
- Introduction
- Serum biomarkers
- Urine biomarkers
- Tissue-based biomarkers
- Next-generation biomarkers
- Summary
- Disclosure
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 50-1
- Published: November 23, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323940191
- eBook ISBN: 9780323940207
AF
Adam Feldman
Affiliations and expertise
Assistant Professor, Surgery, Harvard Medical School, Assistant in Urology, Urology, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center